Cargando…
The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery
PURPOSE: Despite the benefits of bariatric surgery for many patients, there are a proportion of patients who do not achieve adequate weight loss. We evaluate the role of liraglutide as adjuvant pharmacotherapy in those who respond poorly to weight loss surgery. MATERIALS AND METHODS: A non-controlle...
Autores principales: | Colbourne, James R. M., Fisher, Oliver M., Mo, Shirley, Rigas, Georgia S., Talbot, Michael L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984502/ https://www.ncbi.nlm.nih.gov/pubmed/36867261 http://dx.doi.org/10.1007/s00423-023-02805-8 |
Ejemplares similares
-
Fertility, pregnancy and post partum management after bariatric surgery: a narrative review
por: Cheah, Sarah, et al.
Publicado: (2022) -
Outcomes of a Third Bariatric Procedure for Inadequate Weight Loss
por: Daigle, Christopher R., et al.
Publicado: (2014) -
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
por: Muratori, Fabrizio, et al.
Publicado: (2022) -
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
por: Frikke-Schmidt, Henriette, et al.
Publicado: (2019) -
Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post‐bariatric surgery
por: Wharton, Sean, et al.
Publicado: (2019)